Before any COVID-19 vaccines can be made available in South Africa, they must be authorised by South Africa’s medicines regulator—the South African Health Products Regulatory Authority (SAHPRA). Catherine Tomlinson explores how SAHPRA is preparing to review and authorise the use of COVID-19 vaccines in the country and the different authorisation approaches they may use.
Immunity to COVID-19 is much more interesting and much more complicated than simply something you do or do not have. Kathryn Cleary spoke to two experts about what we know about COVID-19 immunity and the implications of that for antibody testing and the development of vaccines.
Scientific research on COVID-19 has been published at an unprecedented scale and speed, but some fear that this is at the cost of scientific rigour. Adele Baleta explores the pros and cons of high-speed science.
South African researchers are poised to start enrolling patients in a landmark international clinical trial which will compare the safety and effectiveness of four different drugs or drug combinations against COVID-19.
South Africa’s strategy to defeat COVID-19 (Coronavirus Disease 2019) is to lockdown the country and upscale testing to quickly identify individuals who may have been infected with the SARS-CoV-2 virus.